A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders by Pedersen, Carsten Bøcker et al.
Copyright 2014 American Medical Association. All rights reserved.
A Comprehensive Nationwide Study of the Incidence Rate
and Lifetime Risk for TreatedMental Disorders
Carsten Bøcker Pedersen, DrMedSc; Ole Mors, PhD; Aksel Bertelsen, MD; Berit LindumWaltoft, MSc;
Esben Agerbo, DrMedSc; John J. McGrath, MD; Preben BoMortensen, DrMedSc; WilliamW. Eaton, PhD
IMPORTANCE Understanding the epidemiologic profile of the life course of mental disorders is
fundamental for research and planning for health care. Although previous studies have used
population surveys, informative and complementary estimates can be derived from
population-based registers.
OBJECTIVE To derive comprehensive and precise estimates of the incidence rate of and
lifetime risk for anymental disorder and a range of specific mental disorders.
DESIGN, SETTING, AND PARTICIPANTS We conducted a follow-up study of all Danish residents
(5.6 million persons), to whom all treatment is provided by the government health care
systemwithout charge to the patient, from January 1, 2000, through December 31, 2012
(total follow-up, 59.5 million person-years). During the study period, 320 543 persons
received first lifetime treatment in a psychiatric setting for anymental disorder; 489 006
persons were censored owing to death; and 69 987 persons were censored owing to
emigration. Specific categories of mental disorders investigated included organic mental
disorders, substance abuse disorders, schizophrenia, mood disorders, anxiety, eating
disorders, personality disorders, mental retardation, pervasive developmental disorders, and
behavioral and emotional disorders.
EXPOSURES Age and sex.
MAIN OUTCOMES ANDMEASURES Sex- and age-specific incidence rates and cumulative
incidences and sex-specific lifetime risks.
RESULTS During the course of life, 37.66% of females (95% CI, 37.52%-37.80%) and 32.05%
of males (31.91%-32.19%) received their first treatment in a psychiatric setting for anymental
disorder. The occurrence of mental disorders variedmarkedly between diagnostic categories
and by sex and age. The sex- and age-specific incidence rates for manymental disorders had a
single peak incidence rate during the second and third decades of life. Some disorders had a
second peak in the sex- and age-specific incidence rate later in life.
CONCLUSIONS AND RELEVANCE This nationwide study provides a first comprehensive
assessment of the lifetime risks for treatedmental disorders. Approximately one-third of the
Danish population received treatment for mental disorders. The distinct signatures of the
different mental disorders with respect to sex and age have important implications for service
planning and etiologic research.
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U nderstanding the life-coursepatternof incidence ratesand themagnitudeof the lifetime risks formental dis-ordersareessential steps for rationalplanningofhealth
care services. In addition, because incidence represents the
force of morbidity in the population,1 variations in incidence
ofdifferentmentaldisordersduringa lifetimeandbetween the
sexes provide clues for understanding causes of the disor-
ders. Community-based surveys have provided an important
foundation forunderstanding theoccurrenceofcommonmen-
tal disorders.2-6 For example, the Epidemiologic Catchment
Area Study2 estimated that 32% of the US population had a
mental disorder at some time in their lives. Subsequent stud-
ies reported even higher lifetime prevalences of nearly 50%3
and 46.4%.5 Some reports7 have been greeted with skepti-
cism, and others8 suggested that the community-based sur-
veys included mild or transient disorders and false-positive
cases of individuals with dramatic styles of personal presen-
tation but little illness or impairment, thus inflating lifetime
prevalences. Within the last decade, a European study9 esti-
mated the lifetime prevalence of the range of mental disor-
ders to be 26%.
Frequency estimates characterize the occurrence of dis-
ease in human populations and therefore are fundamental to
descriptive andetiologic investigations. They enableus tode-
scribe how common an illness is in relation to the size of the
population. Distinguishing between incidence, which re-
flects thenumberofnewcaseswithin agiven time, andpreva-
lence, which reflects the number of existing cases at a given
point, is important. Incidence measures are typically esti-
mated from cohort studies that involve follow-up of popula-
tions. For most chronic diseases, 1 person can experience a
single onset throughout life. For recurrent diseases suchas re-
spiratory illnesses and includingpsychiatric disorders such as
recurrent depression, we may wish to estimate incidence by
assessing onsets that occur during a given period after recov-
ery from an earlier episode. However, the first occurrence is
often of greater interest than subsequent occurrences in the
same individual, because that first occurrencemay linkmore
strongly to the hypothesized force ofmorbidity.1,10 In this re-
port, we are studying first occurrences only.
Incidence rates of 1 or more mental disorders have been
estimated by age and sex in population-based prospective
surveys.11-19However, thesmallnumberof incidentcases, even
with thousandsofperson-yearsofobservation, introducedun-
certainty in the estimated curves during the course of life.
The sex- and age-specific incidence rate of disease occur-
rence is the instantaneous potential for change in disease sta-
tus for each sex and age, relative to the sex- and age-specific
size of the population. Others have referred to this concept as
instantaneous risk, hazard, hazard rate, person-time inci-
dence rate, first lifetime incidence rate, incidence, rate, and force
ofmorbidity. The incidence rate refers to apopulation andhas
noeasy interpretationon the individual level.10However, hav-
ing estimated sex- andage-specific incidence rates for thedis-
order of interest (and all competing events), sex- and age-
specific cumulative incidences can be estimated readily.20,21
Onthe individual level, thecumulative incidencemeasures the
probability of being affected with the disorder before a given
age. Others have referred to this concept as incidence propor-
tion, conditional probability, cumulative incidence function, cu-
mulative incidence proportion, and risk. The cumulative inci-
dence at a late age (eg, 100 years) is an estimate of a lifetime
risk,whereas the prevalence is not. In addition,many studies
failed to account for censoringowing to emigrationanddeath,
or they lacked the data.22
Although lifetime risk estimates are useful for individual
prediction of risk and assessment of societal burden, no pre-
vious studypresented suchestimates for awide rangeofmen-
tal disorders.5Because individualswithmental disordershave
increased risks of death17,23,24 and emigration,25 the lifetime
prevalence estimates of population-based surveys are under-
estimates of lifetime risks because they do not include per-
sonswho have emigrated or died before the time of the inter-
view. The lifetime prevalence is sometimes called the
proportion of survivors affected andhas been estimated as the
percentage of subjects in a survey who had the disorder be-
fore the interview.26 The lifetime risk allows estimationof the
percentage of persons in the populationwhowill develop the
disorder before the end of their life. The lifetime prevalence
estimates theproportionof survivorswith thedisease,whereas
the lifetime risk estimates the probability of having the disor-
der throughout life.
Epidemiologic techniques are available to derive lifetime
risks based on population-based health registers.22 Nation-
widemental health registerswith unique personal identifiers
are available in some developed nations now, but in general
these registers have not been suitable for estimating lifetime
risks, because they have not been in operation long enough
to capture the entire lifetime, and becausemany registers are
not representative of the general population. The few studies
that have used health registers have focused on only single
disorders.27-29Weundertookacomprehensivestudyof the life-
time risk for mental disorders treated in secondary care set-
tings—that is, apsychiatrichospital, specialtypsychiatric clinic,
or emergency department—based on the entire Danish popu-
lation. InDenmark,medical treatment is providedby the gov-
ernmenthealthcare systemwithoutcharge to thepatient,with
national andprospective registration for all individuals in sec-
ondary care since 1969.Weestimated sex- andage-specific in-
cidence rates and cumulative incidences for a wide range of
mental disorders. The incidence ratemeasures thenumber of
persons treated for the first time in their lifeper 10 000person-
years at risk. The cumulative incidence measures the ex-
pected percentage of persons in the population who will be
treated for thedisorder before a givenage.Wedefined the life-
time riskas thecumulative incidenceat the 100thbirthday.Be-
cause we use competing risk survival analyses, persons need
not to be alive at the 100th birthday to contribute to the esti-
mation of the lifetime risk.
Methods
Study Population
TheDanishCivilRegistrationSystem30wasestablished in1968,
when all people alive and residing in Denmark were regis-
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tered. At present, 5.6 million persons live in Denmark. From
1968 onward, the system includes the personal identification
number, sex, date of birth, and continuously updated infor-
mation on vital status. The personal identification number is
used in all national registers, enabling accurate linkage be-
tween registers and avoidingduplicationof prior episodes oc-
curring anywhere else in the nation. Our studypopulation in-
cluded all persons born in Denmark from January 1, 1900,
through December 31, 2010.
This study was approved by the Danish Data Protection
Agency. By Danish law, informed consent is not required for
register-based studies.
Assessment ofMental Illness
The study population was linked with the Danish Psychiatric
Central Research Register31 to obtain information on mental
illness treated in secondary care. From 1969 the Danish Psy-
chiatric Central Register contained data on all admissions to
Danish psychiatric inpatient facilities; from 1995, informa-
tiononall contacts to outpatient psychiatric departments and
visits to psychiatric emergency care unitswas included. Den-
mark has no private psychiatric hospitals, and all visiting pa-
tients are registered in the Danish Psychiatric Central Re-
searchRegister. From1969 to 1993, thediagnostic systemused
was the Danish modification of the International Classifica-
tion of Diseases, 8th Revision (ICD-8)32; from 1994, the ICD-10
Classification ofMental andBehavioural Disorders: Diagnostic
Criteria for Research (ICD-10-DCR).33 Individuals were classi-
fiedwith amental disorder if theyhadbeenadmitted to apsy-
chiatric hospital, received outpatient psychiatric care, or vis-
itedapsychiatricemergencycareunit.Thespectrumofspecific
mental disorders considered is shown in Table 1. Individuals
withmore than 1 disorderwere included in the numerator for
each specific disorder. For each mental disorder, the date of
onset was defined as the first day of the first contact (inpa-
tient, outpatient, or psychiatric emergency care unit), given
the diagnosis of interest.
Study Design
Persons were followed up from January 1, 2000, or the earli-
est age at which a personmight possibly develop the specific
disorder (Table 1), whichever came later. Follow-up was ter-
minated at the first treatment of the disorder, death, emigra-
tion from Denmark, or December 31, 2012, whichever came
first. The findings were based on putative incident cases di-
agnosedaccording to the ICD-10-DCRclassificationsystemdur-
ing a period when inpatient and outpatient information was
included in the register. To reduce the risk thatprevalent cases
withaccess to servicesbefore theperiodofobservation (ie, be-
fore 2000) were misclassified as incident cases, we excluded
individuals who had been diagnosed using the ICD-8 classifi-
cation and/or during the first 6 years of the operation of the
ICD-10-DCR system. This stringent washout rule meant that
our incident cases could not have previously accessed ser-
vices for the psychiatric condition of interest for a 31-year pe-
riod from1969 through1999.Thisprocedurewasused for each
disorder separately. Sensitivity analyses that extended the
washout period to 36 years revealed nearly identical results.
We included only persons who were alive and resided in
Denmark at initiation of follow-up to control for possible
increased risk for mental disorders associated with
immigration.34,35
Statistical Analysis
Weestimated sex- andage-specific incidence rates and cumu-
lative incidences of the first occurrenceof anypsychiatric dis-
order (ICD-8 codes 290-315; ICD-10-DCR codes F00-F99) and
a number of separate mental disorders (Table 1). The inci-
dence ratemeasures thenumberofpersons treated for the first
time in their life per 10 000 person-years at risk, and the cu-
mulative incidencemeasures thepercentagesofpersons in the
populationwhowill be treated for the disorder before a given
age. We define the lifetime risk as the cumulative incidence
at the 100th birthday. Cumulative incidenceswere calculated
for each sex and mental disorder separately and were esti-
mated using competing risk survival analyses to account for
the fact that persons are simultaneously at risk for a mental
disorder, death, or emigration from Denmark. Ignoring cen-
soring from emigration and/or death will bias the estimated
incidence rates downward and the estimated cumulative in-
cidences upward.22 Because we use competing risk survival
analyses, persons need not be alive at their 100th birthday to
contribute to the estimation of the lifetime risk. The 100th
birthday was chosen to ensure that disorders from birth
throughout the entire life course were enumerated.
Results
The cohort of 5.6millionDanish residentswas followedup for
59.5millionperson-years; the longest individual follow-upwas
13 years (2000-2012). A total of 320 543 persons had their first
psychiatric contact for anypsychiatric disorder during follow-
up;489 006personswerecensoredowing todeath; and69 987
persons were censored owing to emigration from Denmark.
The lifetime risk for any psychiatric disorder was 37.66%
for a female and32.05%for amale (Table 2). Table 2 also shows
the probability of having a psychiatric contact for each disor-
der before 50 years of age.
Figure 1, Figure 2, and the Supplement (eFigures 1 to 5)
show the sex- and age-specific incidence rates and cumula-
tive incidences foranypsychiatricdisorderandthespecificpsy-
chiatric disorders investigated. These incidence curves dis-
play differences that may be regarded as epidemiologic
signatures and suggest clues to causes thatmaybe connected
to particular periods of the life course. For example, organic
mental disorders (Figure 1A) showed an onset late in life for
which both sexes had almost identical age-specific incidence
rates. That similarity can be compared with the sharp rise in
incidence rateofpsychoactive substanceabusedisorders from
10 to 20 years of age, then a drop until about 30 years of age
(Figure 1B). Females had a risewith a second peak at about 45
years of age and then a decline thereafter. The probability of
first treatment for any disorder from, for example, 20 to 40
years of age, is estimated as the cumulative incidence at age
40 years minus the cumulative incidence at age 20 years.
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Both sexes had almost identical incidence rates and cu-
mulative incidences for schizophrenia during childhood and
adolescence, but from 20 to 50 years of age,males had higher
incidence rates and cumulative incidences (Figure 1C). We
found some indication that after 50 years of age, females had
higher incidence rates thanmales,whichbecamemorepromi-
Table 1. Diagnostic Classification ofMental Disorders According to the ICD-10-DCR and Equivalent ICD-8Diagnoses
Diagnosis
ICD-10-DCR
Codesa Equivalent ICD-8 Codes
Earliest Possible
Age at Onset, y
No. of Prevalent
Cases Before
Follow-up
No. of Persons at
Risk at Initiation of
Follow-up
No. of New
Cases During
Follow-up
Any psychiatric disorder F00-F99 290-315 1 249 956 5 364 461 320 543
Organic, including symptomatic,
mental disorders
F00-F09 290.09, 290.10,
290.11, 290.18,
290.19, 292.x9,
293.x9, 294.x9,
309.x9
35 24 001 3 508 367 66 539
Dementia in Alzheimer disease F00 290.09, 290.10,
290.19
35 6109 3 526 259 25 756
Vascular dementia F01 293.09, 293.19 35 3059 3 529 309 11 865
Mental and behavioral disorders
due to psychoactive substance
abuse
F10-F19 291.x9, 294.39,
303.x9, 303.20,
303.28, 303.90,
304.x9
10 66 352 4 965 624 53 645
Mental and behavioral disorders
due to alcohol use
F10 291.x9, 303.x9,
303.20, 303.28,
303.90
10 51 986 4 979 990 37 332
Mental and behavioral disorders
due to cannabis use
F12 304.59 10 6114 5 025 862 12 179
Schizophrenia and related
disorders
F20-F29 295.x9, 296.89,
297.x9, 298.29-298.99,
299.04, 299.05,
299.09, 301.83
10 45 610 4 986 366 30 217
Schizophrenia F20 295.x9 (excluding
295.79)
10 19 713 5 012 263 14 364
Schizoaffective disorder F25 295.79, 296.89 10 4460 5 027 516 2442
Mood disorders F30-F39 296.x9 (excluding
296.89), 298.09,
298.19, 300.49,
301.19
10 73 873 4 958 103 113 565
Bipolar disorders F30-F31 296.19, 296.39,
298.19
10 12 664 5 019 312 13 682
Recurrent depressive disorder F33 296.09, 296.29,
298.09, 300.49b
10 22 362 5 009 614 48 532
Single and recurrent depressive
disorder
F32-F33 296.09, 296.29,
298.09, 300.49
10 62 795 4 969 181 105 108
Neurotic, stress-related, and
somatoform disorders
F40-F48 300.x9 (excluding
300.49), 305.x9,
305.68, 307.99
5 89 213 5 261 721 139 929
Obsessive-compulsive disorder F42 300.39 5 2506 5 348 428 10 242
Eating disorders F50 305.60, 306.50,
306.58, 306.59
1 5176 5 609 241 12 480
Anorexia nervosa F50.0 306.50 1 2096 5 612 321 3673
Specific personality disorders F60 301.x9 (excluding
301.19), 301.80,
301.81, 301.82,
301.84
10 71 965 4 960 011 41 477
Borderline-type F60.31 301.84 10 6636 5 025 340 9265
Mental retardation F70-F79 311.xx, 312.xx,
313.xx, 314.xx,
315.xx
1 5560 5 608 857 12 703
Pervasive developmental disorders F84 299.00, 299.01,
299.02, 299.03
1 3270 5 611 147 16 824
Childhood autism F84.0 299.00 1 828 5 613 589 4725
Behavioral and emotional disorders
with onset usually occurring
in childhood and adolescence
F90-F98 306.x9, 308.0x 1 13 807 5 600 610 44 473
Hyperkinetic disorder F90 308.01 1 2522 5 611 895 27 699
Abbreviations: ICD-8, International Classification of Diseases, 8th Revision;
ICD-10-DCR, ICD-10 Classification of Mental and Behavioural Disorders:
Diagnostic Criteria for Research.
a Inclusive of diagnostic categories for which a valid conversion to the ICD-8
code was possible.
b For recurrent depression, onset was defined as the second admission that
occurred at least 8 weeks after last discharge with these ICD-8 codes.
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nent when a more inclusive category (schizophrenia and re-
lated disorders) was examined (Supplement [eFigure 3A]).
Both sexeshadabimodaldistributionof the incidence rate
ofmooddisorder, and females hadhigher incidence rates and
cumulative incidenceofmooddisorders thanmales at all ages
(Figure 1D). For both sexes, a sharp rise in incidence rate oc-
curred from 10 to 20 years of age, then a drop until about 65
years, and thena risewithasecondhighpeakatabout85years.
Figure 2 and the Supplement (eFigures 1 to 5) show the
curves for the remainingdisorders investigated.Overall, these
line graphs showdistinct sex- and age-specific patterns of in-
cidence rates and cumulative incidence. For example, eating
disorders (Figure 2A) showed a female excess and early on-
set, with a dramatic drop in the incidence rate at the age of 30
years;mental retardation (Figure 2B), pervasivedevelopmen-
taldisorders (Figure2C), andhyperkineticdisorders (Figure2D)
showed a male excess and an early onset.
Sex- and age-specific incidence rates and cumulative in-
cidences for anypsychiatric disorder and for all 25 specific dis-
orders investigatedareavailableon theauthors’website (http:
//ncrr.au.dk/en/publications). These estimates are identical to
those presented in Table 2, Figures 1 and 2, and the Supple-
ment (eFigures 1-5).
Discussion
Based on the present findings, one-third of the Danish popu-
lationwill receive treatment in secondarycare for amentaldis-
order across their lifetime. The incidence rates and cumula-
tive incidenceofmental disorders varymarkedlybetween the
sexes andacross the rangeof ages. As expected,we foundma-
jor sexdifferences in certaindisorders.Malesweremore likely
to receive treatment for disorders such as autism, mental re-
tardation, hyperkinetic disorders, schizophrenia, and sub-
stance use disorders, whereas womenweremore likely to re-
ceive treatment for anxiety, mood disorders, and eating
disorders. We estimate that 3.67% of females and 3.78% of
Table 2. Lifetime Risk and Cumulative Incidence at 50 Years of Age for All Psychiatric Disorders
Psychiatric Disorder ICD-10-DCR Code
Cumulative Incidence (95% CI), %a Lifetime Risk (95% CI), %b
Males Females Males Females
Any psychiatric disorder F00-F99 22.60 (22.49-22.73) 25.26 (25.13-25.39) 32.05 (31.91-32.19) 37.66 (37.52-37.80)
Organic, including symptomatic,
mental disorders
F00-F09 0.41 (0.40-0.43) 0.26 (0.24-0.27) 8.84 (8.74-8.95) 11.98 (11.87-12.09)
Dementia in Alzheimer disease F00 0.01 (0.01-0.01) 0.01 (0.01-0.02) 3.20 (3.13-3.27) 5.14 (5.06-5.22)
Vascular dementia F01 0.01 (0.01-0.01) 0.01 (0.00-0.01) 1.85 (1.80-1.90) 2.01 (1.96-2.06)
Mental and behavioral disorders due
to psychoactive substance abuse
F10-F19 5.96 (5.89-6.03) 2.95 (2.90-3.00) 7.79 (7.71-7.87) 4.49 (4.43-4.55)
Mental and behavioral disorders
due to alcohol use
F10 3.52 (3.47-3.58) 1.76 (1.72-1.80) 5.28 (5.22-5.35) 2.96 (2.91-3.01)
Mental and behavioral disorders
due to cannabis use
F12 2.12 (2.08-2.17) 0.77 (0.74-0.79) 2.20 (2.15-2.24) 0.79 (0.76-0.82)
Schizophrenia and related disorders F20-F29 3.06 (3.01-3.12) 2.43 (2.39-2.48) 3.78 (3.73-3.84) 3.67 (3.61-3.73)
Schizophrenia F20 1.73 (1.69-1.77) 1.24 (1.21-1.28) 1.93 (1.89-1.97) 1.56 (1.53-1.60)
Schizoaffective disorder F25 0.17 (0.16-0.18) 0.25 (0.24-0.27) 0.22 (0.20-0.23) 0.35 (0.33-0.37)
Mood disorders F30-F39 6.24 (6.17-6.31) 10.89 (10.79-10.98) 9.95 (9.86-10.04) 16.48 (16.37-16.59)
Bipolar disorders F30-F31 0.76 (0.73-0.78) 1.07 (1.04-1.10) 1.32 (1.29-1.36) 1.84 (1.80-1.88)
Recurrent depressive disorder F33 2.13 (2.08-2.17) 4.46 (4.39-4.52) 3.78 (3.72-3.84) 7.62 (7.53-7.70)
Single and recurrent depressive
disorder
F32-F33 5.63 (5.57-5.70) 10.18 (10.09-10.27) 9.07 (8.98-9.16) 15.50 (15.39-15.61)
Neurotic, stress-related, and
somatoform disorders
F40-F48 10.28 (10.19-10.37) 15.80 (15.69-15.91) 12.51 (12.41-12.61) 18.97 (18.85-19.09)
Obsessive-compulsive disorder F42 0.90 (0.87-0.93) 1.45 (1.42-1.49) 0.95 (0.92-0.98) 1.55 (1.51-1.58)
Eating disorders F50 0.17 (0.16-0.18) 2.96 (2.91-3.01) 0.17 (0.16-0.19) 3.00 (2.95-3.06)
Anorexia nervosa F50.0 0.05 (0.04-0.06) 0.87 (0.85-0.90) 0.05 (0.04-0.06) 0.89 (0.86-0.92)
Specific personality disorders F60 3.12 (3.07-3.18) 6.06 (5.98-6.13) 3.45 (3.40-3.51) 6.66 (6.58-6.74)
Borderline-type F60.31 0.24 (0.23-0.26) 2.08 (2.04-2.13) 0.25 (0.24-0.27) 2.13 (2.08-2.17)
Mental retardation F70-F79 1.58 (1.55-1.62) 0.96 (0.93-0.99) 1.79 (1.75-1.82) 1.16 (1.13-1.19)
Pervasive developmental disorders F84 2.96 (2.91-3.02) 0.92 (0.89-0.95) 3.00 (2.94-3.05) 0.93 (0.90-0.96)
Childhood autism F84.0 0.86 (0.84-0.89) 0.22 (0.21-0.24) 0.87 (0.85-0.90) 0.23 (0.21-0.24)
Behavioral and emotional disorders
with onset usually occurring in
childhood and adolescence
F90-F98 6.83 (6.76-6.91) 3.45 (3.40-3.51) 6.88 (6.80-6.95) 3.50 (3.45-3.56)
Hyperkinetic disorder F90 4.52 (4.46-4.58) 1.90 (1.85-1.94) 4.55 (4.48-4.61) 1.92 (1.88-1.96)
Abbreviation: ICD-10-DCR, ICD-10 Classification of Mental and Behavioural
Disorders: Diagnostic Criteria for Research.
a Measures the probability of being treated for the disorder before 50 years of
age. Individuals with more than 1 disorder were included in the numerator for
each of the separate disorders.
bMeasures the cumulative incidence at 100 years of age.
Rate of and Risk for Mental Disorders in Denmark Original Investigation Research
jamapsychiatry.com JAMAPsychiatry May 2014 Volume 71, Number 5 577
Downloaded From: http://archpsyc.jamanetwork.com/ by a UQ Library User  on 10/12/2015
Copyright 2014 American Medical Association. All rights reserved.
males received treatment for schizophrenia and related dis-
orders (Table 2) and that 15.50% and 9.07% of females and
males, respectively, received treatment for depression. Neu-
rotic, stress-related, and somatoform disorders (females,
18.97%; males, 12.51%); mood disorders (females, 16.48%;
males, 9.95%); andorganicmental disorders (females, 11.98%;
males,8.84%)hadhighest lifetimerisks forbothsexes (Table2).
Mostmental disorders have their peak age at onset in the
secondandthirddecadesof life,whereasorganicdisorders like
dementia have late onset. Mood disorders had a bimodal age
distribution,36 with peaks in the early third and in the ninth
decades of life suggesting thepossibility of differing causes.37
Thebimodaldistribution fordisordersof substanceabuse sug-
gests that different substancesmay be abused (eg, marijuana
and cocaine in youth and alcohol in older adults).
Although lifetime prevalences and lifetime risks are not
directly comparable, our overall estimates for treated life-
time risks for mental disorders are somewhat lower than US-
basedcommunitysurveys4,38,39 thathave found lifetimepreva-
lence ranging from 40% to 50%. In the World Mental Health
Survey Initiative,6 the interquartile range for the lifetimepreva-
lence of anymental disorder was 12% to 47%, thus capturing
ourestimateof the lifetime risk for anymentaldisorder inDen-
mark (32.05%formales and37.66%for females). Formoodand
substance use disorders, the interquartile ranges from the
World Mental Health Surveys6 were 9.8% to 15.8% and 4.8%
to 9.6%, respectively, which are in the same range of the esti-
mates in Table 2. However, the World Mental Health Surveys
and the US surveys included a spectrum of common mental
disorders,whereaswewere able to include a broader range of
mental disorders and childhood psychiatric disorders.
The risk estimates of mental disorders in a given popula-
tion are influenced by the study design, which affects the va-
lidity and the generalizability of the results. Register-based
studies such as the present one cannot capture persons with
untreateddisorders; however, population-based surveys can-
Figure 1. Sex- and Age-Specific Incidence Rates and Cumulative Incidences for OrganicMental Disorders, Substance Abuse Disorders, Schizophrenia,
andMoodDisorders
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A, Organic mental disorders (ICD-10 Classification of Mental and Behavioural
Disorders: Diagnostic Criteria for Research [ICD-10-DCR] codes F00-F09). B,
Mental and behavioral disorders due to psychoactive substance abuse
(ICD-10-DCR codes F10-F19). C, Schizophrenia (ICD-10-DCR code F20). D, Mood
disorders (ICD-10-DCR codes F30-F39). Limit lines show the 95% CIs in
designated age ranges. Owing to the large sample size, the confidence intervals
for the cumulative incidences are very close to the estimates and are therefore
not shown. The incidence rates measure the number of persons per 10 000
person-years treated for the first time. The cumulative incidencemeasures the
probability (per 100 persons) of being treated for the disorder before a given
age. Because the cumulative incidences are estimated continuously with
respect to age and the incidence rates are estimated in age intervals, the
abscissa for the cumulative incidencemeasures the exact age, whereas the
abscissa for the incidence rates measures the lowest cutoff point for the age
interval. For example, the incidence rate of mood disorder for females aged
50-54.99 years is 19.60 (95% CI, 19.01-20.22) per 10 000 person-years at risk,
and the cumulative incidence for females at 50 years of age is 10.89%
(10.79%-10.98%).
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not capture persons who emigrated or died before the inter-
viewandare less able to capturepersonswhodonot give con-
sent to be interviewed; who are living in institutions, group
homes, jails, or prisons; who are homeless; or who are cur-
rently in inpatient treatment.Also, surveyparticipantsmaynot
report past disorders.40 Therefore, the strength and weak-
ness of the register-based approach contrasts and comple-
ments thoseof the surveyapproach.Themajor strengthof the
register-based approach is the comprehensive clinical assess-
ment of allmental disorders treated in secondary care in ana-
tionwidepopulation,whereas themajor strength in thesurvey-
basedapproach is theuseofstandardizeddiagnostic interviews
for those persons not necessarily in treatment. The contrast-
ing methods of diagnosis do not agree well41; clinician-
deriveddiagnoseshave several strengths41 (eg, access tomen-
tal health records, details from family members and key
informants, andoverall clinical judgment) butmay lack the re-
liability that canbeobtainedbywell-trained interviewersusing
standardized diagnostic interviews.42 Although systematic
studiesvalidatingall clinical diagnosespresented in this study
are not available, many of the key diagnoses (ie, schizophre-
nia, a single depressive episode, affective disorder, demen-
tia, and autism) have been validated with good results.43-47
Our study is based on contacts with inpatient and outpa-
tient psychiatric departments and visits to psychiatric emer-
gency department units in a nation where treatment is pro-
vided through the government health care system without
charge to the individual and without any private psychiatric
hospital. Financial factors are thus less likely to influencepath-
ways tocare in this studycomparedwithmanyothernations.48
The population studied is representative of the Danish popu-
lation, because all residents of Denmark are included, inde-
pendentlyofdemographic, social, andhealth-related issues.30
The estimates presented herein provide a lower bound-
ary of the proportion of the populationwho had experienced
a mental disorder during their life, because not all individu-
als with mental disorders seek treatment,48 and some do so
after many years.49 The estimates for severe mental disor-
ders, forwhichmost people eventually receive treatment, are
more likely to be accurate, comparedwith estimates formen-
tal disorders of mild or moderate severity, where a propor-
tionwill not be treated in secondarymental health care. Such
cases are diagnosed and treated by the general practitioners
inDenmark,andsomepatientswithanxiety, affective, andper-
sonality disorders may be treated by specialists in psychiatry
working in private practice only. These patients are not regis-
Figure 2. Sex- and Age-Specific Incidence Rates and Cumulative Incidences for Eating Disorders, Mental Retardation, Pervasive Developmental
Disorders, and Hyperkinetic Disorder
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A, Eating disorders (ICD-10 Classification of Mental and Behavioural Disorders:
Diagnostic Criteria for Research [ICD-10-DCR] code F50). B, Mental retardation
(ICD-10-DCR code F70-F79). C, Pervasive developmental disorders (ICD-10-DCR
code F84). D, Hyperkinetic disorder (ICD-10-DCR code F90). Limit lines show
the 95% CIs in designated age ranges. Owing to the large sample size, the
confidence intervals for the cumulative incidences are very close to the
estimates and are therefore not shown. Incidence rates and cumulative
incidence are described in Figure 1.
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tered in the Danish Psychiatric Central Register. However, if
they visit a psychiatric inpatient or outpatient clinic or a psy-
chiatric emergency care unit for their disorders, these pa-
tients will be registered, albeit with a delayed age of onset.
Therefore, the age-specific pattern for the severe mental dis-
orders likely represents the true age-specific incidence of the
disorder, whereas the age-specific pattern for the less severe
disorders may show a delayed age-specific pattern of the
disorder.
Despite this conservative bias of our approach, the over-
all estimate of lifetime risk is close to the lifetimeprevalences
presented in community surveys.2-6 The early onset formany
mental disorders, combined with other information on dis-
ability andchronicity ofmental disorders, helps to explain the
sizable burden of disability-adjusted life-years attributable to
mental disorders.50
As with any other study of health-related outcomes, our
estimates may be biased by birth cohort effects (eg, differ-
ences in prenatal care, differences in childhood vaccination
schedules). No evidence of birth cohort effects exists during
the ICD-10-DCR period for the disorders studied, except for
autism.28
The novelty of this report is the comprehensive nation-
wide assessment of lifetime risks, sex- and age-specific inci-
dence rates, and sex- and age-specific cumulative incidences
ofmental disorders treated in secondary careduring a full life-
time. The curves for anorexia and the similarity inmales and
females for schizophrenia are novel. Bimodalities in the life-
coursepatterns ofmoodand substanceusedisorders haveoc-
casionally been reported, but neverwith such high precision.
The distinct signatures of the different mental disorders
have important implications for service planning and etio-
logic research.With respect to service planning, our register-
based findings should guide allocation of future health care
funding51 in terms of total demand estimated over the life-
time, the agedistributions expected at different treatment fa-
cilities, and theages atwhichprimarypreventionactivities are
targeted. The incidence rates confirm that a large proportion
of mental disorders reach secondary care during the second
and third decades of life, consistent with the renewed focus
on the global public health needs of young people.52 At the
other extreme of life, our estimates provide a stark reminder
about the steep rise in the onset of mental disorders after 60
years of age, including late-occurringmooddisorders andAlz-
heimer disease.
Conclusions
This nationwide studyprovides a first comprehensive assess-
mentof the lifetime risks for treatedmentaldisorders. Thedis-
tinct signatures of the different mental disorders with re-
spect to sex and age have important implications for service
planning and etiologic research.
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